DNA Stock Analysis: Buy, Sell, or Hold?
DNA - Ginkgo Bioworks Holdings, Inc.
$8.97
-0.34 (-3.65%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 24, 2026
23d
Smart Money Accumulation
DNA is down 10.5% this week, but smart money is accumulating calls. Top strike: $11 2026-03-20 with 658 OI. Call ratio: 69% View Scanner →
Strength: 7.1/10
Get Alerted When DNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: DNA is down 10.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: DNA is down 10.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: DNA is currently trading at $8.97, which is considered fair relative to its 30-day fair value range of $8.64 to $9.85.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $8.63, while resistance sits at $11.10. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (16th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $8.63, while resistance sits at $11.10. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (16th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$8.64 -
$9.85
Company Quality Score
55/100
(HOLD)
Options IV Signal
16th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
71.7%
Protect Your Profits
Holding DNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 16th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.7%)
- NEUTRAL: Near Wall St target ($10.00)
- WARNING: Recommendation downgraded due to -10.5% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$8.64 -
$9.85
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$1.14
(12.7%)
Support & Resistance Levels
Support Level
$8.63
Resistance Level
$11.10
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.56
Wall Street Target
$10.00
(+7.4%)
Revenue Growth (YoY)
-56.4%
Profit Margin
-188.0%
Last updated: January 31, 2026 9:27 AM ET
Data refreshes hourly during market hours. Next update: 10:27 AM
Data refreshes hourly during market hours. Next update: 10:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Steven P Coen
SELL
1312 shares
2025-10-17
Steven P Coen
SELL
5609 shares
2025-10-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$65 | 60 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$42 | 53 HOLD |
Advanced DNA Option Strategies
Professional options setups generated by AI based on today's DNA price and gamma walls.
